No abstract available
MeSH terms
-
Antibiotics, Antineoplastic / administration & dosage
-
Antibiotics, Antineoplastic / therapeutic use*
-
Antineoplastic Agents, Phytogenic / therapeutic use
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / pathology
-
Breast Neoplasms / therapy
-
Clinical Trials, Phase II as Topic
-
Clinical Trials, Phase III as Topic
-
Cross-Over Studies
-
Disease Progression
-
Disease-Free Survival
-
Doxorubicin / adverse effects
-
Doxorubicin / analogs & derivatives*
-
Doxorubicin / therapeutic use
-
Female
-
Follow-Up Studies
-
Humans
-
Liposomes
-
Multicenter Studies as Topic
-
Neoplasm Metastasis
-
Paclitaxel / therapeutic use
-
Paresthesia / chemically induced
-
Polyethylene Glycols / adverse effects
-
Polyethylene Glycols / therapeutic use*
-
Quality of Life
-
Randomized Controlled Trials as Topic
-
Research Design
-
Treatment Outcome
Substances
-
Antibiotics, Antineoplastic
-
Antineoplastic Agents, Phytogenic
-
Liposomes
-
liposomal doxorubicin
-
Polyethylene Glycols
-
Doxorubicin
-
Paclitaxel